Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lan G Coffman

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
JCI Insight|May 6, 2020
Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancerJason R Brown, Daniel K Chan, Jessica J Shank, et al.
Cancer Research|April 16, 2026
RHOV is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal MetastasisAmal T Elhaw, Priscilla W Tang, Ya-Yun Cheng, et al.
Cancer Discovery|March 14, 2025
Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell TransformationGeyon L Garcia, Taylor Orellana, Grace Gorecki, et al.
EMBO Reports|August 27, 2024
Drp1 splice variants regulate ovarian cancer mitochondrial dynamics and tumor progressionZaineb Javed, Dong Hui Shin, Weihua Pan, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
Alternative splice variants of the mitochondrial fission protein <i>DNM1L</i>/Drp1 regulate mitochondrial dynamics and tumor progression in ovarian cancerZaineb Javed, Dong Hui Shin, Weihua Pan, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
The chemotherapy-induced senescence-associated secretome promotes cell detachment and metastatic dissemination through metabolic reprogrammingAidan R Cole, Raquel Buj, Apoorva Uboveja, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
JCI Insight|May 6, 2020
Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancerJason R Brown, Daniel K Chan, Jessica J Shank, et al.
Cancer Research|April 16, 2026
RHOV is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal MetastasisAmal T Elhaw, Priscilla W Tang, Ya-Yun Cheng, et al.
Cancer Discovery|March 14, 2025
Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell TransformationGeyon L Garcia, Taylor Orellana, Grace Gorecki, et al.
EMBO Reports|August 27, 2024
Drp1 splice variants regulate ovarian cancer mitochondrial dynamics and tumor progressionZaineb Javed, Dong Hui Shin, Weihua Pan, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
Alternative splice variants of the mitochondrial fission protein <i>DNM1L</i>/Drp1 regulate mitochondrial dynamics and tumor progression in ovarian cancerZaineb Javed, Dong Hui Shin, Weihua Pan, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
The chemotherapy-induced senescence-associated secretome promotes cell detachment and metastatic dissemination through metabolic reprogrammingAidan R Cole, Raquel Buj, Apoorva Uboveja, et al.
Pageof 3